WHAT PATIENTS ARE NOT BEING TOLD
Despite the hype created with relative risk reduction (RRR), the Absolute Risk Reduction (ARR) for COVID Vaccines is around 1%. The ARR for Pfizer-BioNTech is only 0.84% (THAT IS CLOSE TO ZERO!)
Although the RRR considers only participants who could benefit from the vaccine, the absolute risk reduction (ARR), which is the difference between attack rates with and without a vaccine, considers the whole population. ARRs tend to be ignored because they give a much less impressive effect size than RRRs: 1·3% for the AstraZeneca–Oxford, 1·2% for the Moderna–NIH, 1·2% for the J&J, 0·93% for the Gamaleya, and 0·84% for the Pfizer–BioNTech vaccines. Lancet Microbe-July 1, 2021 National Institutes of Health – April 20, 2021
Risk Benefit for Males ages 16-29
The incidence of myocarditis increased after the receipt of the Pfizer’s BNT162b2 vaccine, particularly after the second dose among young male recipients.
The largest difference among male recipients between the ages of 16 and 19 years (difference, 13.73 per 100,000 persons; 95% CI, 8.11 to 19.46), highest after the second dose in male recipients between the ages of 16 and 19 years (13.60; 95% CI, 9.30 to 19.20).
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel October 6, 2021
The highest incidence of myocarditis (10.69 cases per 100,000 persons; 95% CI, 6.93 to 14.46) was reported in male patients between the ages of 16 and 29 years. October 6, 2021
CDC Leaked July 29, 2021 Slide Questions Rational Basis For Discriminatory Burden Placed Upon Unvaccinated or Those Asserting Medical Privacy
Comparing the COVID Jab to other vaccines.
Significantly – the risk of injury is substantially higher than other vaccines
COVID jab – does not guarantee a person will not become infected by COVID-19 – “Covid-19 Breakthrough Infections in Vaccinated Health Care Workers” – New England Journal of Medicine – July 28, 2021 DOI:10.1056/NE/Moa2109072. Many had symptoms lingering beyond 6 weeks. (Personal Note – I personally know several vaccinated persons suffering from “rare” COVID-19 breakthrough infections)